Shuang Wu

机构：Tongde Hospital of Zhejiang Province, First Hospital of China Medical University, China Medical University · ORCID：0009-0006-3437-8740

发表论文 32 篇 · 总被引 288 次 · h-index 8

代表论文

• Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease (2023 · JAMA Neurology · 被引 99)
• Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study (2023 · Journal of Hematology & Oncology · 被引 23)
• Regulation of inflammation by Chaihu-Shugan-San: Targeting the IL-17/ NF-κB pathway to combat breast cancer-related depression (2025 · Phytomedicine · 被引 22)
• Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy (2020 · Journal of Gastrointestinal Oncology · 被引 19)
• Clinical effectiveness of matrine sitz bath in treating perianal infection after chemotherapy for acute leukemia (2020 · Annals of Palliative Medicine · 被引 14)
• The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines (2019 · Journal of Clinical Pathology · 被引 11)